Kuliczkowski, Wiktor MD, PhD1; Derzhko, Roksolana MD, PhD1,2; Prajs, Iwona MD, PhD3; Podolak-Dawidziak, Maria MD, PhD3; Serebruany, Victor L MD, PhD4*
Departments of 1Cardiology, 2Pharmacology, and 3Hematology, Wroclaw Medical University, Wroclaw, Poland; and 4HeartDrug Research, Johns Hopkins University, Baltimore, MD.
The authors have no conflicts of interest to declare.
*Address for correspondence: HeartDrug™ Research Laboratories, Osler Medical Center, 7600 Osler Drive, Suite 307, Towson, MD 21204. E-mail: [email protected]